Our study successfully evaluated the integration of EMA and IBG analyses into routine newborn C4 screening and distinguished SCADD/IBDD from other C4-associated disorders (36). The gene discussed is C4A; the disease is short chain acyl-CoA dehydrogenase deficiency.